BACK TO TOP
KSE100
169,864.52
1289.83
(0.77%)
KSE100PR
53,363.10
405.21
(0.77%)
ALLSHR
102,725.12
553.85
(0.54%)
KSE30
51,670.42
495.07
(0.97%)
KMI30
244,230.81
2126.85
(0.88%)
BKTI
45,511.24
335.27
(0.74%)
OGTI
33,787.04
288.90
(0.86%)
KMIALLSHR
67,141.82
438.06
(0.66%)
PSXDIV20
74,249.34
310.07
(0.42%)
UPP9
58,271.22
530.43
(0.92%)
NITPGI
43,735.35
460.87
(1.06%)
NBPPGI
48,028.85
435.56
(0.92%)
MZNPI
30,157.52
227.42
(0.76%)
JSMFI
45,908.57
428.89
(0.94%)
ACI
25,012.83
202.48
(0.82%)
JSGBKTI
66,784.15
485.63
(0.73%)
HBLTTI
17,734.29
11-12-2025
5.27
(0.03%)
MII30
22,342.69
219.35
(0.99%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.379.81
2.35
(0.62%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Dec 12, 2025 4:40 PM
REG
DFC
CSF
ODL
Open
382.00
High
382.00
Low
375.00
Volume
9,463
CIRCUIT BREAKER
339.71 — 415.21
DAY RANGE
375.00 — 382.00
52-WEEK RANGE ^
242.33 — 464.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
377.46
VAR
11.50
HAIRCUT
15.00
P/E Ratio (TTM) **
28.95
1-Year Change * ^
2.43%
YTD Change * ^
13.26%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.

KEY PEOPLE
Osman Khalid WaheedCEO
Akhter Khalid WaheedChairperson
Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
16,509,980.26
Shares
43,469,051
Free Float
15,214,168
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2025Transmission of Quarterly Financial Statements for the Period Ended 30-09-2025 View   PDF
Oct 27, 2025Financial Results for the Quarter Ended 2025-09-30 View   PDF
Oct 3, 2025Transmission of Annual Financial Statements for the Year Ended 30-06-2025 View   PDF
Sep 23, 2025Financial Results for the Year Ended 30-06-2025 View   PDF
Apr 30, 2025Transmission of Quarterly Report for the Period Ended 2025-03-31 View   PDF
DateTitleDocument
Oct 27, 2025Certified True Copies of the Resolutions passed in the 69th Annual General Meeting of the Company View   PDF
Oct 17, 2025Board Meeting View   
Oct 3, 2025Notice of Annual General Meeting View   PDF
Oct 2, 2025Notice of Annual General Meeting prior to publication View   PDF
Sep 16, 2025Board Meeting View   
DateTitleDocument
Nov 20, 2025Corporate Briefing Session - Presentation View   PDF
Nov 18, 2025Corporate Briefing Session View   PDF
Nov 5, 2025Credit of Final Cash Dividend View   
May 19, 2025Material Information View   PDF
Nov 26, 2024Corporate Briefing Session - Presentation View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales13,857,96712,711,7149,893,3917,806,414
Profit after Taxation528,243400,054189,042514,149
EPS12.159.204.3511.83
Q1 2026Q3 2025Q2 2025Q1 2025
Sales3,883,2523,778,6893,676,1063,356,579
Profit after Taxation182,420138,117111,815140,511
EPS4.203.182.573.23
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)41.2738.8838.6345.06
Net Profit Margin (%)3.813.151.916.59
EPS Growth (%)32.07111.49(63.23)(40.91)
PEG1.000.24(0.50)(0.56)

Payouts

Financial Reports